Discharge Clinical Characteristics and Post-Discharge Events in Patients with Severe COVID-19: A Descriptive Case Series

Faysal Saab, Jeffrey N. Chiang, Rachel Brook, Paul C. Adamson, Jennifer A. Fulcher, Eran Halperin, Vladimir Manuel, David Goodman‐MezaJournal of General Internal Medicine 2021 · DOI

Abstract

Our data suggest that neither persistent fever, oxygen requirement, nor laboratory marker derangement was associated with need for acute care in the 30-day period after discharge for severe COVID-19. These findings suggest that physicians need not await the normalization of laboratory markers, resolution of fever, or discontinuation of oxygen prior to discharging a stable or improving patient with COVID-19.

Introduction

During the early waves of the SARS-CoV-2 pandemic, clinicians faced a daunting triage dilemma: determining when a patient with severe COVID-19 is truly safe for discharge. Standard clinical practice often leans toward caution, requiring patients to be afebrile for 24–48 hours, off supplemental oxygen, and for laboratory markers such as C-reactive protein (CRP) or D-dimer to return to baseline. However, in a pandemic setting, "waiting for normal" consumes critical bed space and increases the risk of nosocomial complications. This study investigates whether common clinical "red flags" at the time of discharge actually correlate with poor outcomes, specifically emergency department (ED) visits or hospital readmissions within 30 days.

Methods

Researchers conducted a retrospective chart review of 147 patients hospitalized at the UCLA Medical Center between March and May 2020. The final cohort included 99 adult inpatients after excluding pediatric, pregnant, or deceased patients. Data were manually extracted regarding inflammatory markers (Ferritin, CRP, LDH, D-dimer, and procalcitonin), vital signs (highest temperature within 24 hours of discharge), and oxygen requirements.

Statistical associations with 30-day post-discharge events were tested using a one-way ANCOVA, adjusting for age and sex, with post hoc pairwise T-tests (Tukey HSD) to identify specific group differences.

Results

The study observed a low overall event rate, with only 10.1% of patients (n=10) experiencing a post-discharge event (5 ED visits and 5 readmissions). Analysis revealed no statistically significant association between 30-day readmission/ED visits and several common discharge criteria:

  • CRP (p = 0.82)
  • D-dimer (p = 0.58)
  • Ferritin (p = 0.58)
  • Oxygen requirement at discharge (p = 0.62)

Notably, nearly a third (31.3%) of patients were discharged while still requiring supplemental oxygen, yet only one of these patients required readmission. Furthermore, while 4% of patients were febrile in their final 24 hours of hospitalization, none required subsequent acute care.

Trajectories of laboratory markers from initial result to discharge, categorized by post-discharge outcomes.

The only marker showing a statistically significant association with readmission was a low absolute lymphocyte count (ALC). Patients who were readmitted had a mean ALC of 0.55 × 10E3/μL, significantly lower than those who did not require further acute care (p = 0.004).

Discussion

These findings suggest that physiological recovery in severe COVID-19 often lags behind clinical stability. Because inflammatory markers have variable plasma half-lives, a patient may achieve clinical stability while markers remain elevated. The data indicate that home oxygen is a viable and safe strategy for freeing up acute care beds and that the rigid "48-hour afebrile" rule may not be necessary for this population.

Limitations

The study is limited by its small sample size and single-center design, which restricts the statistical power to detect subtle associations. Additionally, the data were collected early in the pandemic before the widespread use of corticosteroids, which significantly alter inflammatory marker trajectories. Future research should involve larger, multi-center datasets to validate these findings and explore the relationship between discharge markers and "Long COVID" symptoms.

Summary updated

Abstract

Our data suggest that neither persistent fever, oxygen requirement, nor laboratory marker derangement was associated with need for acute care in the 30-day period after discharge for severe COVID-19. These findings suggest that physicians need not await the normalization of laboratory markers, resolution of fever, or discontinuation of oxygen prior to discharging a stable or improving patient with COVID-19.
BibTeX
@article{saab2021discharge,
  author = {Faysal Saab and Jeffrey N. Chiang and Rachel Brook and Paul C. Adamson and Jennifer A. Fulcher and Eran Halperin and Vladimir Manuel and David Goodman‐Meza},
  title = {{Discharge Clinical Characteristics and Post-Discharge Events in Patients with Severe COVID-19: A Descriptive Case Series}},
  journal = {Journal of General Internal Medicine},
  year = {2021},
  doi = {10.1007/s11606-020-06494-7},
}
Figure